Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

NCT02497118 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Endostatin
DRUG: Vinorelbine
DRUG: Cisplatin

Sponsor

Tianjin Medical University Cancer Institute and Hospital